An experimental blood test for Parkinson’s disease is over 90% accurate in diagnosing the progressive disorder that affects movement and balance, according to its developers.
The newly approved drug Zelboraf appears to nearly double the length of time a person can expect to live with advanced melanoma skin cancer, a new study shows.
A new drug to treat advanced skin cancer, or metastatic melanoma, has been shown to nearly double average survival time in a study of more than 130 patients, researchers said Wednesday.
The Y chromosome is just a fraction of its original size, and much smaller than its buxom partner, the X chromosome, but researchers say its gene-shedding days seem to be over.
A sizable proportion of people who are taken to hospitals for heart attacks — more than a third, and more women than men — do not have chest pain and, as a result, may not receive lifesaving treatment.
NEW YORK (Reuters Health) – About 15 percent of surgeons have alcohol abuse or dependency problems, a rate that is somewhat higher than the rest of the population, according to a new survey.
Low-dose aspirin may be just as effective as the more expensive Plavix when combined with a walking program to treat leg pain that’s associated with narrowing of the leg arteries.
Scientists on Wednesday said they had uncovered the first molecular proof that the “biological clock” is linked to a type of sudden, fatal heart attack.